Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Lung Cancer
Interventions
DEVICE

Patients treated for their lung cancer.

"In addition to the weekly Moovcare® Lung follow-up, patients will benefit from standard oncological follow-up at the discretion of their oncologist according to standard recommendations for 2 years. Questionnaires will be completed at different times as mentioned below on the global study scheme and Flowchart.~In an active treatment situation, the pace of consultations will be adapted to the pace of treatment administration, according to standard recommendations. It may be lengthened in the absence of a clinical application or biological alert at the discretion of the investigator."

Trial Locations (15)

13915

AP-HM La Timone, Marseille

44600

Clinique mutualiste de l'ESTUAIRE, Saint-Nazaire

50100

Centre Hospitalier Public du Cotentin, Cherbourg

57070

Hopital Robert Schumann, Vantoux

59000

Centre Oscar Lambret, Lille

64046

CHU de PAU, Pau

67091

Nouvel Hôpital Civil, Strasbourg

69400

Hôpital Nord-Ouest, Gleizé

75005

Institut Curie, Paris

77150

Hôpital Forcilles, Férolles-Attilly

87039

Polyclinique de Limoges - Site de François CHENIEUX, Limoges

92210

Institut Curie, Saint-Cloud

92300

Hopital Franco Britannique, Levallois-Perret

95100

Chu Argenteuil, Argenteuil

06100

Clinique Saint-George, Nice

All Listed Sponsors
lead

Institut Curie

OTHER

NCT04934865 - Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG | Biotech Hunter | Biotech Hunter